Free PSA
Test Overview
The Free PSA (Prostate-Specific Antigen) test measures the level of unbound (free) PSA in the blood. PSA is a protein produced by the prostate gland, and it exists in two forms in the bloodstream:
- Bound PSA (attached to proteins).
- Free PSA (circulating freely).
This test is particularly useful in assessing prostate health and helping differentiate between benign prostate conditions and prostate cancer.
Test Uses
- Evaluate prostate health in men with elevated Total PSA levels.
- Differentiate between benign prostate conditions (BPH, prostatitis) and prostate cancer.
- Guide decisions on the need for a prostate biopsy.
- Monitor prostate conditions over time.
Free PSA Test Results & Ranges
| Test Component: | Normal Range: | Abnormal (Possible Conditions): |
|---|---|---|
| Free PSA | Varies based on Total PSA levels | Lower Free PSA (%) → Higher risk of prostate cancer. Higher Free PSA (%) → More likely to be benign prostate hyperplasia (BPH) or other non-cancerous conditions. |
Free PSA Percentage Interpretation
| Free PSA % | Risk of Prostate Cancer |
|---|---|
| >25% | Low risk |
| 10-25% | Intermediate risk |
| <10% | High risk |
- A low Free PSA percentage (<10%) is more commonly seen in men with prostate cancer.
- A high Free PSA percentage (>25%) suggests a benign condition like BPH (benign prostatic hyperplasia).
Expected Turnaround Time
- Results Available: Typically within 24 – 48 hours.
Specimen Requirements
- Sample Type: Blood sample (venipuncture).
- Container: Serum separator tube (SST, gold or red-top tube).
Collection Instructions
- Fasting: Not required.
- Avoid ejaculation for 24–48 hours before testing, as it can temporarily elevate PSA levels.
- Avoid recent prostate manipulations, such as a digital rectal exam (DRE) or catheterization, as they can also impact PSA levels.
Test Details
Clinical Use: The Free PSA test is primarily used when Total PSA is between 4.0 – 10.0 ng/mL, a “gray zone” where cancer risk is uncertain. A higher Free PSA percentage suggests a benign condition, while a lower Free PSA percentage indicates a higher likelihood of prostate cancer. Helps reduce unnecessary biopsies in men with elevated Total PSA.
Limitations: Not a standalone diagnostic test—should be interpreted alongside Total PSA and other clinical factors. Some men with prostate cancer may still have high Free PSA levels, making further testing (e.g., biopsy) necessary.
The Free PSA test is a valuable tool for assessing prostate cancer risk, particularly in men with elevated Total PSA levels, helping guide further diagnostic decisions.